Energy peptides FAQ

Expect that. MOTS-c signals mitochondrial biogenesis. The generation of new mitochondria. Which requires 4–6 weeks before measurable changes in cellular ATP capacity occur. Subjective energy improvements typically emerge around week 6–8 in twice-weekly dosing protocols. If you feel nothing by week 10, verify peptide potency (most failures trace to storage issues or underdosed preparations) and confirm NAD+ substrate availability isn't rate-limiting. Add NMN 500mg daily and reassess at week 12.

Yes, but it depends on pathway overlap. MOTS-c and Humanin target similar mitochondrial biogenesis pathways. Stacking them delivers additive rather than synergistic results (roughly 1.3× benefit instead of 2×). Combining MOTS-c (biogenesis) with SS-31 (electron transport efficiency) and NMN (NAD+ substrate) targets three separate rate-limiting steps, which compounds effects. Avoid stacking more than three peptides simultaneously. You lose the ability to identify which compound is driving outcomes and increase the risk of receptor downregulation.

Discard it immediately. Cloudiness indicates protein aggregation or bacterial contamination. Both render the peptide ineffective and potentially unsafe. Properly reconstituted peptide solutions are clear and colourless. If using bacteriostatic water (0.9% benzyl alcohol), a faint alcohol odour is normal. Any yellow, brown, or particulate matter signals degradation. Do not inject compromised solutions. The financial loss is preferable to injecting denatured protein aggregates that can trigger immune responses.

Verify your dosing timing first. Administering GHRPs during the daytime or within two hours of meals suppresses the GH pulse you're trying to amplify. Measure IGF-1 levels at baseline and week four. If IGF-1 hasn't increased by at least 30%, either the peptide was underdosed, improperly stored (temperature excursion denatures the protein), or you're dosing during suppressed circadian windows. If IGF-1 has increased but energy hasn't improved, the fatigue mechanism isn't GH-related. Consider mitochondrial support peptides like Cerebrolysin or metabolic modulators like Thymalin instead.

Those are expected ghrelin receptor effects. Appetite stimulation occurs because ghrelin is the primary hunger hormone, and MK-677 mimics it systemically. Water retention results from aldosterone elevation (a secondary effect of GH increase). Both effects typically stabilize after 10–14 days as receptors downregulate. If water retention persists beyond three weeks or causes discomfort, reduce the dose to 10mg daily rather than 25mg. Half the dose produces 70% of the IGF-1 increase with significantly less fluid retention. Timing the dose before bed also reduces daytime hunger signaling.

Stack CJC-1295 with Ipamorelin for GH pathway amplification, then add Cerebrolysin for mitochondrial support if cognitive fatigue dominates. Don't combine two GHRPs in the same protocol. They compete for the same receptor and produce diminishing returns. Avoid stacking peptides with overlapping mechanisms until you've measured the response to each individually. Real Peptides provides detailed reconstitution and storage protocols with every order to prevent cross-contamination when running multi-peptide research.